Health and Human Services News and Research

RSS

ARIAD reports $20.4 million net loss for third quarter 2010

ARIAD Pharmaceuticals, Inc. today reported financial results for the third quarter and nine months ended September 30, 2010 and provided an update on corporate developments.

9 Nov 2010

Gentiva third quarter total net revenues increase 38% to $387.8 million

Gentiva Health Services, Inc., a leading provider of home health and hospice services, today reported third quarter 2010 results.

9 Nov 2010

Spectral Molecular Imaging awarded $190,172 QTDP grant for development of melanoma detection system

Cascade Technologies Corp., announced today that its wholly-owned subsidiary Spectral Molecular Imaging, Inc. (SMI) has received a grant under the Qualifying Therapeutic Discovery Project (QTDP) program to advance the development of the company's SkinSpect system for the detection of melanoma and other skin cancers.

9 Nov 2010

Mystic awarded $245,000 QTDP grant for VersiDoser Delivery Platform

Mystic Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of advanced precision ophthalmic and intranasal delivery technologies for drugs and biologics, today announced that it has been awarded a non-taxable grant of approximately $245,000 related to its VersiDoser™ Delivery Platform under the Qualifying Therapeutic Discovery Project (QTDP) program included in the Patient Protection and Affordable Health Care Act of 2010.

9 Nov 2010

Merrimack receives $2.44 million under QTDP program to support cancer research

Merrimack Pharmaceuticals was awarded $2.44 million to support research on 10 of its cancer programs through the Qualifying Therapeutic Discovery Project, a grant program created as part of the Patient Protection and Affordable Care Act of 2010 to advance research in areas of unmet medical need.

9 Nov 2010

Interleukin Genetics receives two grants under QTDP program to advance obesity, osteoarthritis genetic research

Interleukin Genetics, Inc. today announced that on November 1, 2010 notification was received that it has been awarded two grants totaling $473,393 by the United States Government under the Qualifying Therapeutic Discovery Project (QTDP) Program to advance the Company's genetic research projects related to obesity and osteoarthritis.

9 Nov 2010

Epeius receives competitive grant to support Rexin-G oncology product

Epeius Biotechnologies Corporation, a leader in the emerging field of targeted genetic medicine, announced today the receipt of additional financial support for the company's lead oncology product, Rexin-G, from the U.S. Departments of Treasury, Health and Human Services (HHS), and the National Institutes of Health (NIH) in the form of a prestigious competitive grant.

9 Nov 2010

Feds crack down on fraud by issuing new Medicaid rules, helping medical students catch fraud

The Hill Healthwatch: "The Centers for Medicare and Medicaid Services on Friday proposed new rules for the use of private contractors that work for states to audit Medicaid payments. The Recovery Audit Contractors will function similarly to the way they do in the Medicare program, where they audit payments that may have been underpaid or overpaid, and recover overpayments or correct underpayments. … Under the new law, states must establish Medicaid RAC programs by submitting state plan amendments to CMS by December 31" (Pecquet, 11/5).

9 Nov 2010

Family history of HG increases risk of extreme morning sickness during pregnancy

Approximately 60,000 pregnant women are hospitalized each year due to hyperemesis gravidarum (HG), an extreme form of nausea and vomiting that endangers their lives and often forces them to reluctantly terminate their pregnancies.

9 Nov 2010

Government cutting premiums for Pre-Existing Condition Insurance Plan

The federal government is trying to spur enrollment in a new health insurance program for uninsured people with pre-existing medical conditions by slashing rates.

8 Nov 2010

Manhattan awarded $244,279 grant under QTDP program

Manhattan Pharmaceuticals, Inc. announced today that it has been awarded $244,279 in funding under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) credit program. The Company has received this funding for its lead product candidate AST-726 for the treatment of vitamin B12 deficiency.

8 Nov 2010

Angioblast Systems receives $1.2 million in grants under QTDP program

Regenerative medicine company, Mesoblast Limited, today announced that its United States associate company, Angioblast Systems, has been awarded $1.2 million in grants under the United States Government's Qualifying Therapeutic Discovery Project (QTDP) program.

8 Nov 2010

Maine requests exemption from federal law, Southern Calif. hospital pays $5 million to resolve charges of false Medicare claims

Bloomberg: "Maine wants an exemption from the federal health-care law to keep a Wall Street-controlled insurer with a history of allegedly abusive practices from leaving the state. Mila Kofman, Maine's insurance superintendent, asked the U.S. Department of Health and Human Services for a three-year waiver from the law's requirement that insurers spend 80 percent of premium revenues on medical care." The

8 Nov 2010

ST Cardio Technologies receives $244,479 QTDP Program grant to develop Z6 Cardiac Stimulator

ST Cardio Technologies, an innovative developer of products utilized in the diagnosis and treatment of heart arrhythmias, announced today that it has been awarded a grant of $244,479 under the Qualifying Therapeutic Discovery Project (QTDP) Program. The company's grant is related to the development and clinical evaluation of the Z6 Cardiac Stimulator. The amount awarded to ST Cardio Technologies represents the maximum award for a grant under this program.

8 Nov 2010

Rcopia-MU certified as EHR Module by CCHIT

DrFirst announced today that Rcopia-MU, Version 3, is 2011/2012 compliant and was certified as an EHR Module on November 4, 2010, by the Certification Commission for Health Information Technology (CCHIT), an ONC-ATCB, in accordance with the applicable eligible provider certification criteria adopted by the Secretary of Health and Human Services.

8 Nov 2010

Tomophase to commercialize OCT Imaging System for pulmonary applications with QTDP award

Tomophase Corporation, a leading developer of minimally invasive optical coherence tomography (OCT) tissue imaging devices, announced that it has received an award from the Departments of the Treasury and Health and Human Services for the Qualifying Therapeutic Discovery Project (QTDP.)

8 Nov 2010

GeoVax receives $244,500 grant under QTDP program for HIV/AIDS vaccine development

GeoVax Labs, Inc., an Atlanta-based, biopharmaceutical firm dedicated to developing vaccines that prevent and fight Human Immunodeficiency Virus (HIV) infections, today announced that it has been awarded a grant of $244,500 related to its HIV/AIDS vaccine development activities under the Qualifying Therapeutic Discovery Project program.

8 Nov 2010

InNexus receives $116,760 cash grant under QTDP program to develop DXL anti-cancer antibodies

InNexus Biotechnology Inc. a leading drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL) technology, today announced it has been awarded a cash grant by the U.S. government totaling $116,760 for projects related to the Company's development of DXL anti-cancer antibodies.

8 Nov 2010

Illinois life sciences receives $14.5 million in grants under QTDP program

At least 59 Illinois life sciences companies were awarded over $14.5 million in grants or tax credits under the Qualifying Therapeutic Discovery Project (QTDP) program.

8 Nov 2010

Stereotaxis receives $1.5 million in grants under QTDP program

Stereotaxis, Inc. announced today that it has been awarded $1.5 million in grants under the Qualifying Therapeutic Discovery Project Program that was enacted under the Patient Protection and Affordable Care Act of 2010.

4 Nov 2010

Health and Human Services News and Research

ARIAD reports $20.4 million net loss for third quarter 2010

Gentiva third quarter total net revenues increase 38% to $387.8 million

Spectral Molecular Imaging awarded $190,172 QTDP grant for development of melanoma detection system

Mystic awarded $245,000 QTDP grant for VersiDoser Delivery Platform

Merrimack receives $2.44 million under QTDP program to support cancer research

Interleukin Genetics receives two grants under QTDP program to advance obesity, osteoarthritis genetic research

Epeius receives competitive grant to support Rexin-G oncology product

Feds crack down on fraud by issuing new Medicaid rules, helping medical students catch fraud

Family history of HG increases risk of extreme morning sickness during pregnancy

Government cutting premiums for Pre-Existing Condition Insurance Plan

Manhattan awarded $244,279 grant under QTDP program

Angioblast Systems receives $1.2 million in grants under QTDP program

Maine requests exemption from federal law, Southern Calif. hospital pays $5 million to resolve charges of false Medicare claims

ST Cardio Technologies receives $244,479 QTDP Program grant to develop Z6 Cardiac Stimulator

Rcopia-MU certified as EHR Module by CCHIT

Tomophase to commercialize OCT Imaging System for pulmonary applications with QTDP award

GeoVax receives $244,500 grant under QTDP program for HIV/AIDS vaccine development

InNexus receives $116,760 cash grant under QTDP program to develop DXL anti-cancer antibodies

Illinois life sciences receives $14.5 million in grants under QTDP program

Stereotaxis receives $1.5 million in grants under QTDP program

Event guide: 6th Operationalize Expanded Access Programs Summit East eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News